The AOYE Group were proud to support the 2022 ARCS Annual Conference held at the ICC in Sydney this week. The conference welcomed industry professionals, researchers and Australia’s top Universities to unite and educate on medical and clinical reform and regulations.
Shanny Dyer, ARCS CEO is a strong advocate of Chinese Talent
Team Pfizer relaxing at the AOYE booth
The underlying message AOYE heard from all participants was the overwhelming skill shortages and challenges in enabling growth and inhibiting the Australian Health Community.
The specific areas being; · Clinical Research · Regulatory Affairs · Pharmacovigilance · GMP Manufacturing
With China producing 900,000 STEM graduates per year (nearly three times more than the US), AOYE has access to the largest talent pool of commercialised Clinical Researchers and Medical Regulators.
Ian Adams, Head of VP Global Regulatory Transformation and Dr. Duncan Macinnis, Director from MTP Connect, has stated that there are 20 priority gaps that need to be addressed to drive continued sector growth in Meditech and Pharma
Andrew McFadzen – Clinical Trial leader at Ramsays Healthcare, stated the high demand for Clinical Research Program Leaders
תגובות